PUBLISHER: Grand View Research | PRODUCT CODE: 1986310
PUBLISHER: Grand View Research | PRODUCT CODE: 1986310
The global hospital assisted surgical robot procedures market size was estimated at USD 11.07 billion in 2025 and is projected to reach USD 39.42 billion by 2033, growing at a CAGR of 17.3% from 2026 to 2033. The market is driven by the demand for minimally invasive surgeries, which reduce recovery time and complications while improving precision.
Adoption of advanced robotic technologies, rising investments in healthcare infrastructure, and the prevalence of complex surgical conditions are expanding the use of surgical robots. In January 2025, Warren Memorial Hospital in the U.S. began performing robotic-assisted general surgery using the da Vinci Xi system, enabling minimally invasive abdominal procedures with improved precision, reduced tissue damage, and faster patient recovery.
The market is driven by the rising demand for minimally invasive surgeries, which offer enhanced precision, reduced post-operative complications, and shorter patient recovery times. Robotic systems enable surgeons to perform complex procedures with greater accuracy and consistency, improving clinical outcomes and operational efficiency, thereby encouraging hospitals to integrate these technologies.In November 2025, Olean General Hospital in the U.S. announced plans to launch a robotic surgery program with the da Vinci Xi system in early 2026. The technology enables surgeons to perform procedures with precision, offering patients quicker recovery, less pain, and improved outcomes.
Integration of artificial intelligence, high-definition imaging, and multi-armed robotic systems allows healthcare providers to expand procedural capabilities, optimize workflow, and deliver higher-quality surgical care, particularly in tertiary and specialty hospitals. In February 2026, Nova Scotia Health's QEII Health Sciences Centre introduced the da Vinci Xi robot with a USD 2.78 million donor contribution, enabling the province's first robot-assisted colorectal, thoracic, and hepatobiliary surgeries. The system has already supported 56 procedures and expanded access to advanced care across multiple specialties.
Market growth is also propelled by the increasing availability of a skilled surgical workforce trained in robotic-assisted procedures, alongside favorable reimbursement frameworks and growing patient awareness of the benefits of robotic surgery. In February 2026, NHS East of England unveiled its National Cancer Plan, aiming to expand robot-assisted surgeries from 70,000 to 500,000 procedures by 2035 and to improve cancer care through faster diagnostics, specialist-centered treatment, and genomic testing. The plan includes same-day robotic prostatectomies and over 250 minimally invasive thoracic procedures, reducing hospital stays and enhancing recovery for patients across the region.
Global Hospital Assisted Surgical Robot Procedures Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global hospital assisted surgical robot procedures market report based on application, procedure type, procedure complexity, and region: